Xcell Therapeutics Inc. (KOSDAQ: A373110)
Health Care · Biotechnology · KR
₩1,169.00
+9.87% today · -51.6% 1Y
Xcell Therapeutics Inc. (KOSDAQ: A373110) operates in the Biotechnology industry within the Health Care sector. The company is valued at $15.16M.
Over the last twelve months the share price has lost 51.6%, trading between 951.00 and 2.52K.
Tweenvest scores Xcell Therapeutics Inc. across four factors: quality 34/100, value 45/100, growth 60/100. Its strongest factor is growth.
A373110 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.16M
- Revenue (TTM)
- $2.81M
- P/E
- —
- EPS
- -766.66
- Dividend yield
- —
- Beta (5Y)
- 1.32
- 52-week high
- ₩2,520.00
- 52-week low
- ₩951.00
- Avg volume (3M)
- —
- Shares outstanding
- 17.29M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| aTyr Pharma, Inc.NasdaqCM: ATYR | $16.19M | $0.17 | -2.88% |
| Psyence Biomedical Ltd.NasdaqCM: PBM | $16.10M | $4.22 | -15.09% |
| TScan Therapeutics, Inc.NasdaqGM: TCRX | $15.66M | $0.23 | -2.94% |
| Onco-Innovations LimitedCNSX: ONCO | $15.60M | CA$0.32 | -13.51% |
| Read-Gene S.A.WSE: RDG | $15.06M | zł4.96 | -1.59% |
| Dyadic International, Inc.NasdaqCM: DYAI | $14.98M | $0.41 | -7.43% |
| SenzaGen ABOM: SENZA | $14.97M | Skr4.56 | +1.10% |
| Valbiotis SAENXTPA: ALVAL | $14.70M | €0.56 | +0.36% |
Figures last refreshed Oct 18, 2026.